Insulin resistance, incident cardiovascular diseases, and decreased kidney function among nondiabetic american indians: The strong heart study

Diabetes Care

Volumn 36, Issue 10, 2013, Pages 3195-3200

  Zhang, Ying ^a   Lee, Elisa T ^a   Howard, Barbara V ^b,c   Best, Lyle G ^d   Umans, Jason G ^b,e   Yeh, Jeunliang ^a   Wang, Wenyu ^a   Yeh, Fawn ^a   Ali, Tauqeer ^a   Devereux, Richard B ^f   De Simone, Giovanni ^g  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b MEDSTAR RESEARCH INSTITUTE   (United States)

^c Delaware   (United States)

^d MISSOURI BREAKS INDUSTRIES RESEARCH INC   (United States)

^e GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

^g FEDERICO II UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE;

ADULT; AGED; AMERICAN INDIAN; ARTICLE; BEHAVIOR; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DECREASED KIDNEY FUNCTION; DEMOGRAPHY; FEMALE; GENDER; HUMAN; INSULIN RESISTANCE; KIDNEY DYSFUNCTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; OUTCOME ASSESSMENT; PATHOGENESIS; PHYSICAL ACTIVITY; RISK ASSESSMENT; SMOKING; WEIGHT CONTROL;

AGED; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INDIANS, NORTH AMERICAN; INSULIN RESISTANCE; KIDNEY; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS;

EID: 84891853678     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-2368     Document Type: Article

References (40)

1. Lillioja S, Mott DM, Spraul M, et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians.NEngl J Med 1993;329:1988-1992
2. Resnick HE, Jones K, Ruotolo G, et al.; Strong Heart Study. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study. Diabetes Care 2003;26:861-867
3. Després JP, Lamarche B, Mauriège P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996;334:952-957
4. Salonen JT, Lakka TA, Lakka HM, Valkonen VP, Everson SA, Kaplan GA. Hyperinsulinemia is associatedwith the incidence of hypertension and dyslipidemia in middleaged men. Diabetes 1998;47:270-275
5. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18:774-800
6. Ardigò D, Numeroso F, Valtueña S, et al. Hyperinsulinemia predicts hepatic fat content in healthy individuals with normal transaminase concentrations. Metabolism 2005;54:1566-1570
7. Argilés JM, López-Soriano FJ. Insulin and cancer (Review). Int J Oncol 2001;18: 683-687 [Review]
8. Facchini FS, Hua N, Abbasi F, Reaven GM. Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab 2001;86:3574-3578
9. Li C, Ford ES, McGuire LC, Mokdad AH, Little RR, Reaven GM. Trends in hyperinsulinemia among nondiabetic adults in the U.S. Diabetes Care 2006;29:2396-2402
10. Resnick HE; Strong Heart Study Investigators. Metabolic syndrome in American Indians. Diabetes Care 2002;25:1246-1247
11. Lee ET, Welty TK, Fabsitz R, et al. The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol 1990; 132:1141-1155
12. Howard BV, Welty TK, Fabsitz RR, et al. Risk factors for coronary heart disease in diabetic and nondiabetic Native Americans. The Strong Heart Study. Diabetes 1992;41(Suppl 2):4-11
13. Howard BV, Lee ET, Yeh JL, et al. Hypertension in adultAmerican Indians. The Strong Heart Study. Hypertension 1996; 28:256-264
14. Chasson AL, Grady HJ, Stanley MA. Determination of creatinine by means of automatic chemical analysis. Tech Bull Regist Med Technol 1960;30:207-212
15. Vasquez B, Flock EV, Savage PJ, et al. Sustained reduction of proteinuria in type 2 (non-insulin-dependent) diabetes following diet-induced reduction of hyperglycaemia. Diabetologia 1984;26: 127-133
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28: 412-419
17. Resnick HE, Bergman RN, Henderson JA, Nez-Henderson P, Howard BV. Utility of a surrogate measure of insulin resistance in American Indians: the Strong Heart Study. Ethn Dis 2002;12:523-529
18. Kriska AM, Brach JS, Jarvis BJ, et al. Physical activity and gallbladder disease determined by ultrasonography. Med Sci Sports Exerc 2007;39:1927-1932
19. American College of Sports Medicine. Guidelines for Graded Exercise Testing and Exercise Prescription. Philadelphia, PA, Lippincott Williams & Wilkins, 2000
20. Chobanian AV, Bakris GL, Black HR, et al.; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-1252
21. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-553 [see comment]
22. Lee ET, Cowan LD, Welty TK, et al. Allcause mortality and cardiovascular disease mortality in three American Indian populations, aged 45-74 years, 1984- 1988. The Strong Heart Study. Am J Epidemiol 1998;147:995-1008
23. Howard BV, Robbins DC, Sievers ML, et al. LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study. Arterioscler Thromb Vasc Biol 2000;20: 830-835
24. Xu J, Knowler WC, Devereux RB, et al. Albuminuria within the "normal" range and risk of cardiovascular disease and death in American Indians: the Strong Heart Study. Am J Kidney Dis 2007;49: 208-216
25. Lee ET, Howard BV, Wang W, et al. Prediction of coronary heart disease in a population with high prevalence of diabetes and albuminuria: the Strong Heart Study. Circulation 2006;113:2897-2905
26. Zhang Y, Galloway JM, Welty TK, et al. Incidence and risk factors for stroke in American Indians: the Strong Heart Study. Circulation 2008;118:1577-1584
27. Lucove J, Vupputuri S, Heiss G, North K, Russell M. Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study. Am J Kidney Dis 2008;51:21-28
28. Xu J, Lee ET, Devereux RB, et al. A longitudinal study of risk factors for incident albuminuria in diabetic American Indians: the Strong Heart Study. Am J Kidney Dis 2008;51:415-424
29. Reaven GM. The individual components of the metabolic syndrome: is there a raison d'etre? J Am Coll Nutr 2007;26: 191-195
30. DeFronzo RA. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia 2010; 53:1270-1287
31. Brown MS, Goldstein JL. Selective versus total insulin resistance: a pathogenic paradox. Cell Metab 2008;7:95-96
32. Einhorn D, Reaven GM, Cobin RH, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003;9:237-252
33. Howard BV, RomanMJ, Devereux RB, et al. Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial. JAMA 2008;299:1678-1689
34. Fujikawa R,Okubo M, Egusa G, Kohno N. Insulin resistance precedes the appearance of albuminuria in non-diabetic subjects: 6 years follow up study. Diabetes Res Clin Pract 2001;53:99-106
35. Cheng HT, Huang JW, Chiang CK, Yen CJ, Hung KY, Wu KD. Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly. J Clin Endocrinol Metab 2012; 97:1268-1276
36. Chen J, Muntner P, Hamm LL, et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J AmSoc Nephrol 2003;14:469-477
37. Hostetter TH, Rennke HG, Brenner BM. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 1982; 72:375-380
38. Tozawa M, Iseki K, Iseki C, Oshiro S, Ikemiya Y, Takishita S. Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria. Kidney Int 2002;62:1743-1749
39. Zhang Y, Lee ET, Devereux RB, et al. Prehypertension, diabetes, and cardiovascular disease risk in a populationbased sample: the Strong Heart Study. Hypertension 2006;47:410-414
40. Reaven GM. Insulin resistance: the link between obesity and cardiovascular disease. Med Clin North Am 2011;95:875-892